Cargando…
Anaplastic lymphoma kinase inhibitor development: enhanced delivery to the central nervous system
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
AME Publishing Company
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10483074/ https://www.ncbi.nlm.nih.gov/pubmed/37691872 http://dx.doi.org/10.21037/tlcr-23-43 |
| _version_ | 1785102300093612032 |
|---|---|
| author | Hida, Toyoaki |
| author_facet | Hida, Toyoaki |
| author_sort | Hida, Toyoaki |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10483074 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | AME Publishing Company |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104830742023-09-08 Anaplastic lymphoma kinase inhibitor development: enhanced delivery to the central nervous system Hida, Toyoaki Transl Lung Cancer Res Editorial Commentary AME Publishing Company 2023-07-31 2023-08-30 /pmc/articles/PMC10483074/ /pubmed/37691872 http://dx.doi.org/10.21037/tlcr-23-43 Text en 2023 Translational Lung Cancer Research. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) . |
| spellingShingle | Editorial Commentary Hida, Toyoaki Anaplastic lymphoma kinase inhibitor development: enhanced delivery to the central nervous system |
| title | Anaplastic lymphoma kinase inhibitor development: enhanced delivery to the central nervous system |
| title_full | Anaplastic lymphoma kinase inhibitor development: enhanced delivery to the central nervous system |
| title_fullStr | Anaplastic lymphoma kinase inhibitor development: enhanced delivery to the central nervous system |
| title_full_unstemmed | Anaplastic lymphoma kinase inhibitor development: enhanced delivery to the central nervous system |
| title_short | Anaplastic lymphoma kinase inhibitor development: enhanced delivery to the central nervous system |
| title_sort | anaplastic lymphoma kinase inhibitor development: enhanced delivery to the central nervous system |
| topic | Editorial Commentary |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10483074/ https://www.ncbi.nlm.nih.gov/pubmed/37691872 http://dx.doi.org/10.21037/tlcr-23-43 |
| work_keys_str_mv | AT hidatoyoaki anaplasticlymphomakinaseinhibitordevelopmentenhanceddeliverytothecentralnervoussystem |